Lipoatrophic Diabetes in Irs1 /Irs3 Double Knockout Mice
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chapter 7: Monogenic Forms of Diabetes
CHAPTER 7 MONOGENIC FORMS OF DIABETES Mark A. Sperling, MD, and Abhimanyu Garg, MD Dr. Mark A. Sperling is Emeritus Professor and Chair, University of Pittsburgh, Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA. Dr. Abhimanyu Garg is Professor of Internal Medicine and Chief of the Division of Nutrition and Metabolic Diseases at University of Texas Southwestern Medical Center, Dallas, TX. SUMMARY Types 1 and 2 diabetes have multiple and complex genetic influences that interact with environmental triggers, such as viral infections or nutritional excesses, to result in their respective phenotypes: young, lean, and insulin-dependence for type 1 diabetes patients or older, overweight, and often manageable by lifestyle interventions and oral medications for type 2 diabetes patients. A small subset of patients, comprising ~2%–3% of all those diagnosed with diabetes, may have characteristics of either type 1 or type 2 diabetes but have single gene defects that interfere with insulin production, secretion, or action, resulting in clinical diabetes. These types of diabetes are known as MODY, originally defined as maturity-onset diabetes of youth, and severe early-onset forms, such as neonatal diabetes mellitus (NDM). Defects in genes involved in adipocyte development, differentiation, and death pathways cause lipodystrophy syndromes, which are also associated with insulin resistance and diabetes. Although these syndromes are considered rare, more awareness of these disorders and increased availability of genetic testing in clinical and research laboratories, as well as growing use of next generation, whole genome, or exome sequencing for clinically challenging phenotypes, are resulting in increased recognition. A correct diagnosis of MODY, NDM, or lipodystrophy syndromes has profound implications for treatment, genetic counseling, and prognosis. -
Analysis of Gene Expression Data for Gene Ontology
ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins. -
Irs2 and Irs4 Synergize in Non-Leprb Neurons to Control Energy Balance and Glucose Homeostasis#.” Molecular Metabolism 3 (1): 55-63
Irs2 and Irs4 synergize in non- LepRb neurons to control energy balance and glucose homeostasis# The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Sadagurski, Marianna, X. Charlie Dong, Martin G. Myers, and Morris F. White. 2013. “Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis#.” Molecular Metabolism 3 (1): 55-63. doi:10.1016/j.molmet.2013.10.004. http:// dx.doi.org/10.1016/j.molmet.2013.10.004. Published Version doi:10.1016/j.molmet.2013.10.004 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879880 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Original article Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis% Marianna Sadagurski 1,*,**, X. Charlie Dong 1,**,***, Martin G. Myers Jr.2,3, Morris F. White 1,**** ABSTRACT Insulin receptor substrates (Irs1, 2, 3 and Irs4) mediate the actions of insulin/IGF1 signaling. They have similar structure, but distinctly regulate development, growth, and metabolic homeostasis. Irs2 contributes to central metabolic sensing, partially by acting in leptin receptor (LepRb)- expressing neurons. Although Irs4 is largely restricted to the hypothalamus, its contribution to metabolic regulation is unclear because Irs4-null mice barely distinguishable from controls. We postulated that Irs2 and Irs4 synergize and complement each other in the brain. -
Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up of Diabetes Mellitus and Its Complications - 2019
THE SOCIETY of ENDOCRINOLOGY and METABOLISM of TURKEY (SEMT) Clinical Practice Guideline for Diagnosis, Treatment and Follow-up of Diabetes Mellitus and Its Complications - 2019 English Version of the 12th Edition SEMT Diabetes Mellitus Working Group ISBN: 978-605-4011-39-1 CLINICAL PRACTICE GUIDELINE FOR DIAGNOSIS, TREATMENT, AND FOLLOW-UP OF DIABETES MELLITUS AND ITS COMPLICATIONS-2019 © SEMT -2019 This material has been published and distributed by The Society of Endocrinology and Metabolism of Turkey (SEMT). Whole or part of this guideline cannot be reproduced or used for commercial purposes without permission. THE SOCIETY of ENDOCRINOLOGY and METABOLISM of TURKEY (SEMT) Meşrutiyet Cad., Ali Bey Apt. 29/12, Kızılay 06420, Ankara, Turkey Phone. +90 312 425 2072 http://www.temd.org.tr ISBN: 978-605-4011-39-1 English Version of the 12th Edition Publishing Services BAYT Bilimsel Araştırmalar Basın Yayın ve Tanıtım Ltd. Şti. Ziya Gökalp Cad. 30/31 Kızılay 06420, Ankara, Turkey Phone. +90 312 431 3062 Fax +90 312 431 3602 www.bayt.com.tr Printing Miki Matbaacılık San. ve Tic. Ltd. Şti. Matbaacılar Sanayi Sitesi 1516/1 Sk. No. 27 İvedik, Yenimahalle / Ankara, Turkey Phone. +90 312 395 2128 Print Date: October 23, 2019 “Major achievements and important undertakings are only possible through collaborations” “Büyük işler, mühim teşebbüsler; ancak, müşterek mesai ile kabil-i temindir.” MUSTAFA KEMAL ATATÜRK, 1925 PREFACE Dear colleagues, The prevalence of diabetes has been increasing tremendously in the last few decades. As a result , medical professionals/ specialists from different fields encounter many diabetics in their daily practice. At this point, updated guidelines on diabetes management, which take regional specification into consideration is needed. -
Mouse Irs4 Knockout Project (CRISPR/Cas9)
https://www.alphaknockout.com Mouse Irs4 Knockout Project (CRISPR/Cas9) Objective: To create a Irs4 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Irs4 gene (NCBI Reference Sequence: NM_010572 ; Ensembl: ENSMUSG00000054667 ) is located on Mouse chromosome X. 2 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 1 (Transcript: ENSMUST00000067841). Exon 1 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Homozygotes for a targeted null mutation exhibit a 10% reduction in male adult size, slightly impaired oral glucose tolerance, and decreased reproductive ability. Exon 1 starts from about 0.03% of the coding region. Exon 1 covers 100.0% of the coding region. The size of effective KO region: ~3646 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 2 Legends Exon of mouse Irs4 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of start codon is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. The gRNA site is selected outside of these tandem repeats. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of stop codon is aligned with itself to determine if there are tandem repeats. -
Breast Cancer Tumor Suppressors: a Special Emphasis on Novel Protein Nischarin Mazvita Maziveyi and Suresh K
Published OnlineFirst September 21, 2015; DOI: 10.1158/0008-5472.CAN-15-1395 Cancer Review Research Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin Mazvita Maziveyi and Suresh K. Alahari Abstract Tumor suppressor genes regulate cell growth and prevent vast number of cellular processes, including neuronal protection spontaneous proliferation that could lead to aberrant tissue and hypotension. The NISCH promoter experiences hypermethy- function. Deletions and mutations of these genes typically lead lation in several cancers, whereas some highly aggressive breast to progression through the cell-cycle checkpoints, as well as cancer cells exhibit genomic loss of the NISCH locus. Further- increased cell migration. Studies of these proteins are important more, we discuss data illustrating a novel role of Nischarin as as they may provide potential treatments for breast cancers. In this a tumor suppressor in breast cancer. Analysis of this new para- review, we discuss a comprehensive overview on Nischarin, a digm may shed light on various clinical questions. Finally, the novel protein discovered by our laboratory. Nischarin, or imida- therapeutic potential of Nischarin is discussed. Cancer Res; 75(20); zoline receptor antisera-selected protein, is a protein involved in a 4252–9. Ó2015 AACR. Introduction (6, 7). It also interacts with LIM kinase (LIMK) in order to prevent cytoskeletal reorganization (8). Typically, scaffold proteins such Breast cancer initiation and progression involve several genetic as Nischarin are characterized as caretaker genes because their events that can activate oncogenes and/or abrogate the function of effects on tumor growth are indirect. tumor suppressor genes. Tumor suppressor genes are commonly lost or deleted in cancers, facilitating the initiation and progres- sion of cancer through several biological events, including cell Discovery of Nischarin proliferation, cell death, cell migration, and cell invasion. -
IRS4 (NM 003604) Human Tagged ORF Clone Lentiviral Particle – RC218385L4V | Origene
OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC218385L4V IRS4 (NM_003604) Human Tagged ORF Clone Lentiviral Particle Product data: Product Type: Lentiviral Particles Product Name: IRS4 (NM_003604) Human Tagged ORF Clone Lentiviral Particle Symbol: IRS4 Synonyms: CHNG9; IRS-4; PY160 Vector: pLenti-C-mGFP-P2A-Puro (PS100093) ACCN: NM_003604 ORF Size: 3771 bp ORF Nucleotide The ORF insert of this clone is exactly the same as(RC218385). Sequence: OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_003604.1 RefSeq Size: 3939 bp RefSeq ORF: 3774 bp Locus ID: 8471 UniProt ID: O14654 Protein Families: Druggable Genome Protein Pathways: Adipocytokine signaling pathway, Insulin signaling pathway, Neurotrophin signaling pathway, Type II diabetes mellitus MW: 133.6 kDa This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 IRS4 (NM_003604) Human Tagged ORF Clone Lentiviral Particle – RC218385L4V Gene Summary: IRS4 encodes the insulin receptor substrate 4, a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. -
Uncommon Forms of Diabetes
Clinical Medicine 2021 Vol 21, No 4: e337–41 CME: DIABETES Uncommon forms of diabetes Authors: Yun-Ni LeeA and Mohammed SB HudaB Diabetes mellitus is a common condition which all clinicians and insulin independence. It is estimated to account for 1%–2% will encounter in their clinical practice. The most common of patients diagnosed with diabetes and, in the UK, the prevalence form is type 2 diabetes followed by type 1 diabetes. However, of MODY is estimated to be at 108 cases per million.3 However, there are many other atypical forms of diabetes which are it may be a significant underestimate and these figures are not important for a clinician to consider as it can impact on the accurate until large population screening studies are performed. ABSTRACT diagnosis and their management. The most common mutations are hepatocyte nuclear factor-1- This article focuses on maturity onset diabetes of the young alpha (HNF1α; 52%), glucokinase (GCK; 32%) and HNF4α (10%), (MODY), latent autoimmune diabetes in adults (LADA), see Table 2.3 ketosis-prone diabetes and other secondary forms of diabetes such as pancreatic cancer and haemochromatosis. We briefly Hepatocyte nuclear factor-1-alpha gene describe the key clinical features of these forms of diabetes and their investigations and treatment. Formerly called MODY3, mutations on the HNF1α gene on chromosome 3 are associated with a progressive defect of insulin secretion.4 Mutations here also result in low renal threshold for 5 Introduction glucose and thus mutation carriers have detectable glycosuria. In the UK, around 90% of people with diabetes have type 2 diabetes (T2D), around 8% have type 1 diabetes (T1D) and around 2% have other forms of diabetes.1 Key points Typically, we see T1D present in a young, lean patient with Suspect other uncommon forms of diabetes if the clinical marked symptoms of polyuria, polydipsia, weight loss and diabetic picture does not fit type 1 or type 2 diabetes. -
Spatial and Temporal Aspects of Signalling 6 1
r r r Cell Signalling Biology Michael J. Berridge Module 6 Spatial and Temporal Aspects of Signalling 6 1 Module 6 Spatial and Temporal Aspects of Signalling Synopsis The function and efficiency of cell signalling pathways are very dependent on their organization both in space and time. With regard to spatial organization, signalling components are highly organized with respect to their cellular location and how they transmit information from one region of the cell to another. This spatial organization of signalling pathways depends on the molecular interactions that occur between signalling components that use signal transduction domains to construct signalling pathways. Very often, the components responsible for information transfer mechanisms are held in place by being attached to scaffolding proteins to form macromolecular signalling complexes. Sometimes these macromolecular complexes can be organized further by being localized to specific regions of the cell, as found in lipid rafts and caveolae or in the T-tubule regions of skeletal and cardiac cells. Another feature of the spatial aspects concerns the local Another important temporal aspect is timing and signal and global aspects of signalling. The spatial organization of integration, which relates to the way in which functional signalling molecules mentioned above can lead to highly interactions between signalling pathways are determined localized signalling events, but when the signalling mo- by both the order and the timing of their presentations. lecules are more evenly distributed, signals can spread The organization of signalling systems in both time and more globally throughout the cell. In addition, signals space greatly enhances both their efficiency and versatility. -
A Novel Transcript Is Upregulated by Fasting in the Hypothalamus and Enhances Insulin Signalling
Journal of Neuroendocrinology, 2013, 25, 292–301 ORIGINAL ARTICLE © 2012 British Society for Neuroendocrinology A novel Transcript is Up-Regulated by Fasting in the Hypothalamus and Enhances Insulin Signalling B. Chai, J.-Y. Li, D. Fritze, W. Zhang, Z. Xia and M. W. Mulholland Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA. Journal of A transcript of unknown function, regulated by fasting and feeding, was identified by micro- array analysis. The transcript is up-regulated in the fasting state. An 1168-bp cDNA was Neuroendocrinology cloned from rat hypothalamus and sequenced. This sequence is consistent with adipogenesis down-regulating transcript 3 (AGD3) (also known as human OCC-1) mRNA. A protein sequence identical to AGD3 was determined by mass spectrometry. In the rat brain, AGD3 mRNA is distributed in the arcuate nucleus, ventromedial hypothalamus, amygdaloid nuclei, hippocam- pus, and somatic cortex. Double in situ hybridisation showed that AGD3 mRNA is co-localised with pro-opiomelanocortin and neuropeptide Y in arcuate nucleus neurones. AGD3 binds with Correspondence to: insulin receptor substrate 4 and increases insulin-stimulated phospho-Akt and regulates AMP- Michael W. Mulholland, Department activated protein kinase and mammalian target of rapamycin downstream target S6 kinase of Surgery, University of Michigan phosphorylation. Medical School, 2101 Taubman Center, 1500 E. Medical Center Drive, Key words: adipogenesis down-regulating transcript 3, insulin, proopiomelanocortin, neuropeptide Y Ann Arbor, MI 48109-0346, USA (e-mail: [email protected]). doi: 10.1111/j.1365-2826.2012.02378.x Obesity and being overweight represent major public health prob- transcripts (8). When the functional roles have been unclear, these lems. -
Theranostics Phosphorylation of IRS4 by Ck1γ2 Promotes Its Degradation
Theranostics 2018, Vol. 8, Issue 13 3643 Ivyspring International Publisher Theranostics 2018; 8(13): 3643-3653. doi: 10.7150/thno.26021 Research Paper Phosphorylation of IRS4 by CK1γ2 promotes its degradation by CHIP through the ubiquitin/lysosome pathway Xinchun Li1#, Li Zhong1#, Zhuo Wang2#, Huiming Chen1, Dan Liao1, Ruhua Zhang1, Hongyu Zhang3 and Tiebang Kang1 1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. 2. Department of Pathology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. 3. Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China. #These authors contributed equally to this work. Corresponding authors: Dr. Tiebang Kang, Tel: 86-20-8734-3183; Fax: 86-20-8734-3170; E-mail: [email protected] or [email protected] © Ivyspring International Publisher. This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2018.03.12; Accepted: 2018.05.04; Published: 2018.06.07 Abstract IRS4, a member of the insulin receptor substrate protein family, can induce constitutive PI3K/AKT hyperactivation and cell proliferation even in the absence of insulin or growth factors and promote tumorigenesis, but its regulation has only been explored at the transcriptional level. Methods: Scansite was used to predict the potential protein kinases that may regulate the functions of IRS4, and mass spectrometry was used to identify the E3 ligase for IRS4. -
Research Article DIABETIC NEPHROPATHY – a MAJOR
Available online www.ijpras.com International Journal of Pharmaceutical Research & Allied Sciences, 2016, 5(4):132-158 ISSN : 2277-3657 Research Article CODEN(USA) : IJPRPM DIABETIC NEPHROPATHY – A MAJOR MACROVASCULAR COMPLICATION Kehkashan Parveen, Waseem A. Siddiqui*, Mohd Adnan Kausara, Mohammed Kuddusa, Syed Monowar Alam Shahida, Jamal Mohammad Arifa*@ Department of Biochemistry, Lipid Metabolism Laboratory, Jamia Hamdard (Hamdard University), New Delhi–110062, INDIA aDepartment of Biochemistry, College of Medicine, University of Hail, Hail, KSA *Corresponding authors @Present Address: Prof. (Dr.) Jamal Mohammad Arif, Dean, Research and Development, Integral University, Lucknow 226 026, (U.P.) INDIA E-mail:. [email protected] ____________________________________________________________________________________________ ABSTRACT Diabetes mellitus (DM) is a complex, progressive disease, which is accompanied by multiple complications. One of the major complication confronted by patients with diabetes is an increased risk of developing diabetic nephropathy (DN) that often progresses to end-stage renal disease.Pathogenesis of DN is multifactorial. The role of hyperglycemia in the pathogenesis of DN has been previously established by a number of studies.Hyperglycemia induces oxidative stress in the rat kidney and increased oxidative stress in the kidney may trigger apoptosis in renal cells in vitro by inducing DNA fragmentation and stimulating expression of apoptosis-regulatory genes. Hyperglycemia also leads to accumulation of advanced glycation end products (AGE's) in renal cortex. These AGE's play a role in the progression of DN through impairment of matrix proteins in vivo, leading to thickening of glomerular basement membrane and expansion of mesangial matrix. DN is also associated with dyslipidemia, which is characterized by higher plasma levels of total cholesterol, low-density lipoprotein and triglycerides, and lower levels of high-density lipoprotein.